Articles

January 19, 2011 – The U.S. Food and Drug Administration (FDA) granted conditional approval to modify the CoreValve U.S. pivotal clinical trial to eliminate the medical management arm of the study...

January 10, 2011 – European CE mark approval was announced today for the Abbott, Absorb drug-eluting bioresorbable coronary stent. It is the first bioresorbable stent to gain regulatory approval...

December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific...

Aortic stenosis (AS) is one of the most common valvular disorders in older adults, with a prevalence of approximately 8 percent at age 85 (1).

There have only been incremental improvements in intravascular ultrasound (IVUS) over the past decade. However, three new technologies introduced in 2010, and a few more expected to enter trials...

During a time when the U.S. healthcare reform is on the minds of many within the medical community, physicians and hospital administrators are continuously looking for ways to cut spending. One...

In the same fashion that the echocardiogram helped transform the cardiac exam, recent developments in the field of portable ultrasound are providing cardiologists with a new way to visualize the...

For patients with severe hypertension that remains uncontrolled despite medical therapy, radiofrequency (RF) energy can be used in the renal vessels to block nerves involved with the sympathetic...

Over the past few years, there have been three key areas of advancement in cardiovascular ultrasound technology – miniaturization, 3-D/4-D imaging and quantification measurements.

When it comes to interventional cardiology, increasing diagnostic confidence and reducing exam time are paramount to improving overall patient care.